Skip to main content
. Author manuscript; available in PMC: 2023 Apr 28.
Published in final edited form as: Eur J Neurol. 2022 Nov 1;30(2):321–333. doi: 10.1111/ene.15603

Figure 5. Voxel-based morphometry analysis of MRI gray matter (GM) and white matter (WM) patterns of atrophy between GGT, controls and autopsy-proven PSP and CBD patients.

Figure 5

GGT patients have more GM in anterior and medial temporal lobes (left > right), caudate nuclei, anterior cingulate and frontal cortex compared to healthy controls. GGT patients had more GM atrophy in medial temporal lobes compared to PSP and CBD. PSP patients had significantly more WM atrophy in midbrain and medulla oblongata and more GM atrophy in cerebellum. CBD patients had slightly more WM atrophy in motor cortex. Lighter color signifies more atrophy.